PRKAA2 and Cerebral ischemia: Later, Li et al. (2010) tested the neuroprotective actions of metformin using a mouse model of cerebral ischemia for 90 minutes (ischemia/reperfusion) and reported AMPK activation with acute metformin treatment and downregulation with chronic metformin treatment.